T cell recognition of self and altered self antigens

Critical Reviews in Immunology

Volumn 17, Issue 5-6, 1997, Pages 449-462

  Nicholson, Lindsay B ^a   Kuchroo, Vijay K ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Altered peptides; Regulation of autoimmunity; Superagonists; T cell differentiation; T cell recognition

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; AUTOIMMUNITY; CELL SELECTION; CONFERENCE PAPER; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THYMUS;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MODELS, THEORETICAL; MOLECULAR SEQUENCE DATA; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SELF TOLERANCE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0030699338     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (99)

1. Rao, A., Faas, S. J., and Cantor, H., Analogs that compete for antigen binding to an arsonate-reactive T-cell clone inhibit the functional response to arsonate, Cell, 36, 889-895, 1984.
2. 10 (GAT), J. Exp. Med., 140, 648-659, 1974.
3. Schwartz, M., Waltenbaugh, C., Dorf, M. E., et al., Determinants of antigenic molecules responsible for genetically controlled regulation of immune responses, Proc. Natl. Acad. Sci. U.S.A., 73, 2862-2866, 1976.
4. Wraith, D. C., McDevitt, H. O., Steinman, L., et al., T cell recognition as the target for immune intervention in autoimmune disease, Cell, 57, 709-715, 1989.
5. Wraith, D. C., Smilek, D. E., Mitchell, D. J., et al., Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy, Cell, 59, 247-255, 1989.
6. Smilek, D. E., Wraith, D. C., Hodgkinson, S., et al., A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis, Proc. Natl. Acad. Sci. U.S.A., 88, 9633-9637, 1991.
7. Wauben, M. H. M., Boog, C. J. P., Van der Zee, R., et al., Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone, J. Exp. Med., 176, 667-677, 1992.
8. De Magistris, M. T., Alexander, J., Coggeshall, M., et al., Antigen analog-major histocompatibility cornplexes act as antagonists of the T cell receptor, Cell, 68, 625-634, 1992.
9. Evavold, B. D. and Allen, P. M., Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand, Science, 252, 1308-1310, 1991.
10. Racioppi, L., Ronchese, F., Matis, L. A., et al., Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling, J. Exp. Med., 177, 1047-1060, 1993.
11. Sloan-Lancaster, J. and Allen, P. M., Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology, Annu. Rev. Immunol., 14, 1-27, 1996.
12. Valitutti, S., Dessing, M., Aktories, K., et al., Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton, J. Exp. Med., 181, 577-584, 1995.
13. Weiss, A. and Littman, D. R., Signal transduction by lymphocyte antigen receptors, Cell, 76, 263-274, 1994.
14. Valitutti, S., Muller, S., Cella, M., et al., Serial triggering of many T-cell receptors by a few peptide-MHC complexes, Nature, 375, 148-151, 1995.
15. Evavold, B. D., Sloan-Lancaster, J., and Allen, P. M., Tickling the TCR: selective T-cell functions stimulated by altered peptide ligands, Immunol. Today, 14, 602-609, 1993.
16. Schwartz, R. H., T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex, Annu. Rev. Immunol., 3, 237-261, 1985.
17. Sette, A., Buus, S., Colon, S., et al., Structural characteristics of antigen required for its interaction with Ia and recognition by T cells, Nature, 328, 395-399, 1987.
18. Allen, P. M., Matsueda, G. R., Evans, R. J., et al., Identification of the T-cell and Ia contact residues of a T-cell antigenic epitope, Nature, 327, 713-715, 1987.
19. Fox, B. S., Chen, C., Fraga, E., et al., Functionally distinct agretopic and epitopic sites. Analysis of the dominant T cell determinant of moth and pigeon cytochrome c with the use of synthetic peptide antigens, J. Immunol., 139, 1578-1588, 1987.
20. Bjorkman, P. J., Saper, M. A., Samraoui, B., et al., Structure of the human class I histocompatibility antigen HLA-A2, Nature, 329, 506-512, 1987.
21. Fremont, D. H., Matsumura, M., Stura, E. A., et al., Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb, Science, 257, 919-927, 1992.
22. Matsumura, M., Fremont, D. H., Peterson, P. A., et al., Emerging principles for the recognition of peptide antigens by MHC class I molecules, Science, 257, 927-934, 1992.
23. Brown, J. H., Jardetzky, T. S., Gorga, J. C., et al., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1, Nature, 364, 33-39, 1993.
24. Stern, L. J., Brown, J. H., Jardetzky, T. S., et al., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide, Nature, 368, 215-221, 1994.
25. Evavold, B. D., Sloan-Lancaster, J., Wilson, K. J., et al., Specific T cell recognition of minimally homologous peptides: evidence for multiple endogenous ligands, Immunity, 2, 655-663, 1995.
26. Boniface, J. J. and Davis, M. M., T-cell recognition of antigen. A process controlled by transient intermolecular interactions, Annal. NY Acad. Sci., 766, 62-69, 1995.
27. Bentley, G. A., Boulot, G., Karjalainen, K., et al., Crystal structure of the beta chain of a T cell antigen receptor, Science, 267, 1984-1987, 1995.
28. Malchiodi, E. L., Eisenstein, E., Fields, B. A., et al., Superantigen binding to a T cell receptor beta chain of known three-dimensional structure, J. Exp. Med., 182, 1833-1845, 1995.
29. Fields, B. A., Ober, B., Malchiodi, E. L., et al., Crystal structure of the V alpha domain of a T cell antigen receptor, Science, 270, 1821-1824, 1995.
30. Garcia, K. C., Degano, M., Stanfield, R. L., et al., A T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex, Science, 274, 209-219, 1996.
31. Garboczi, D. N., Ghosh, P., Utz, U., et al., Structure of the complex between human T-cell receptor, viral peptide and HLA-A2, Nature, 384, 134-141, 1996.
32. Evavold, B. D., Allen, P. M., Gupta, S., and Waldmann, T. A., Eds., Mechanisms of Lymphocyte Activation and Immune Regulation. IV. Cellular Communications, Plenum Press, New York, 1992 (Dissection of the Hb(64-76) determinant reveals that the T cell receptor may have the capacity to differentially signal.) 17-21.
33. Kuchroo, V. K., Greer, J. M., Kaul, D., et al., A single TCR antagonist peptide inhibits experimental allergic encephalomyelitis mediated by a diverse T cell repertoire, J. Immunol., 153, 3326-3336, 1994.
34. Hemmer, B., Fleckenstein, B. T., Vergelli, M., et al., Identification of high-potency microbial and self ligands for a human autoreactive class II-restricted T cell clone, J. Exp. Med., 185, 1651-1659, 1997.
35. Nelson, C. A., Petzold, S. J., and Unanue, E. R., Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell, Nature, 371, 250-252, 1994.
36. Kumar, V., Bhardwaj, V., Soares, L., et al., Major histocompatability complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells, Proc. Natl. Acad. Sci. U.S.A., 92, 9510-9514, 1995.
37. Chaturvedi, P., Yu, Q., Southwood, S., et al., Peptide analogs with different affinities for MHC alter the cytokine profile of T helper cells, Int. Immunol., 8, 745-755, 1996.
38. + T cells, J. Exp. Med., 182, 1591-1596, 1995.
39. Hosken, N. A., Shibuya, K., Heath, A. W., et al., The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-transgenic model, J. Exp. Med., 182, 1579-1584, 1995.
40. Sette, A., Alexander, J., Ruppert, J., et al., Antigen analogs/MHC complexes as specific T cell receptor antagonists, Annu. Rev. Immunol., 12, 413-431, 1994.
41. Sloan-Lancaster, J., Evavold, B. D., and Allen, P. M., Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells, Nature, 363, 156-159, 1993.
42. Vergelli, M., Hemmer, B., Kalbus, M., et al., Modifications of peptide ligands enhancing T cell responsiveness imply large numbers of stimulatory ligands for autoreactive T cells, J. Immunol., 158, 3746-3752, 1997.
43. Constant, S. L. and Bottomly, K., Induction of Th1 and Th2 CD4+ T cell responses: alternative approaches, Annu. Rev. Immunol., 15, 297-322, 1997.
44. + T cells by antigenic peptides altered for TCR binding, J. Immunol., 158, 4237-4244, 1997.
45. Windhagen, A., Scholz, C., Hollsberg, P., et al., Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand, Immunity, 2, 373-380, 1995.
46. Vergelli, M., Hemmer, B., Utz, U., et al., Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein (87-99), Eur. J. Immunol., 26, 2624-2634, 1996.
47. Hogquist, K. A., Jameson, S. C., Heath, W. R., et al., T cell receptor antagonist peptides induce positive selection, Cell, 76, 17-27, 1994.
48. Ashton-Rickardt, P. G., Bandeira, A., Delaney, J. R., et al., Evidence for a differential avidity model of T cell selection in the thymus, Cell, 76, 651-663, 1994.
49. Hogquist, K. A., Jameson, S. C., and Bevan, M. J., Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells, Immunity, 3, 79-86, 1995.
50. Ausubel, L. J., Kwan, C. K., Sette, A., et al., Complementary mutations in an antigenic peptide allow for crossreactivity of autoreactive T-cell clones, Proc. Natl. Acad. Sci. U.S.A., 93, 15317-15322, 1996.
51. Kersh, G. J. and Allen, P. M., Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands, J. Exp. Med., 184, 1259-1268, 1996.
52. Viola, A. and Lanzavecchia, A., T cell activation determined by T cell receptor number and tunable thresholds, Science, 273, 104-106, 1996.
53. Kim, D. T., Rothbard, J. B., Bloom, D. D., et al., Quantitative analysis of T cell activation: role of TCR/ ligand density and TCR affinity, J. Immunol., 156, 2737-2742, 1996.
54. Madrenas, J., Chau, L. A., Smith, J., et al., The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands, J. Exp. Med., 185, 219-229, 1997.
55. Anderson, D. E., Ausubel, L. J., Krieger, J., et al., Weak peptide agonists reveal functional differences in B7-1 and B7-2 costimulation of human T cell clones, J. Immunol., 1997, in press.
56. Nabavi, N., Freeman, G. J., Gault, A., et al., Signaling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression, Nature, 360, 266-268, 1992.
57. Alberola-Ila, J., Takaki, S., Kerner, J. D., et al., Differential signaling by lymphocyte antigen receptors. Annu. Rev. Immunol., 15, 125-154, 1997.
58. Ruppert, J., Alexander, J., Snoke, K., et al., Effect of T-cell receptor antagonism on interaction between T cells and antigen-presenting cells and on T-cell signaling events, Proc. Natl. Acad. Sci. U.S.A., 90, 2671-2675, 1993.
59. Sloan-Lancaster, J., Shaw, A. S., Rothbard, J. B., et al., Partial T cell signaling - altered phopho-zeta and lack of ZAP-70 recruitment in APL-induced T cell anergy, Cell, 79, 913-922, 1995.
60. Madrenas, J., Wange, R. L., Wang, J. L., et al., Zeta phosphorylation without ZAP-70 activation induced by TCR antagonists or partial agonists, Science, 267, 515-518, 1995.
61. Sloan-Lancaster, J., Steinberg, T. H., and Allen, P. M., Selective activation of the calcium signaling pathway by altered peptide ligands, J. Exp. Med., 184, 1525-1530, 1996.
62. Madrenas, J., Schwartz, R. H., and Germain, R. N., Interleukin 2 production, not the pattern of early T-cell antigen receptor-dependent tyrosine phosphorylation, controls anergy induction by both agonists and partial agonists, Proc. Natl. Acad. Sci. U.S.A., 93, 9736-9741, 1996.
63. Rabinowitz, J. D., Beeson, C., Wulfing, C., et al., Altered T cell receptor ligands trigger a subset of early T cell signals, Immunity, 5, 125-135, 1996.
64. Klinman, N. R., The mechanism of antigenic stimulation of primary and secondary clonal precursor cells, J. Exp. Med., 136, 241-260, 1972.
65. Grossman, Z. and Paul, W. E., Adaptive cellular interactions in the immune system: the tunable activation threshold and the significance of subthreshold responses, Proc. Natl. Acad. Sci. U.S.A., 89, 10365-10369, 1992.
66. Jameson, S. C. and Bevan, M. J., T cell receptor antagonists and partial agonists, Immunity, 2, 1-11, 1995.
67. Madrenas, J. and Germain, R. N., Variant TCR ligands: new insights into the molecular basis of antigen-dependent signal transduction and T-cell activation, Semin. Immunol., 8, 83-101, 1996.
68. McKiethan, T. W., Kinetic proofreading in T-cell receptor signal transduction, Proc. Natl. Acad. Sci. U.S.A., 92, 5042-5046, 1995.
69. Rabinowitz, J. D., Beeson, C., Lyons, D. S., et al., Kinetic discrimination in T-cell activation, Proc. Natl. Acad. Sci. U.S.A., 93, 1401-1405, 1996.
70. Matsui, K., Boniface, J. J., Steffner, P., et al., Kinetics of T-cell receptor binding to peptide/I-Ek complexes: correlation of the dissociation rate with T-cell responsiveness, Proc. Natl. Acad. Sci. U.S.A., 91, 12862-12866, 1994.
71. Lyons, D. S., Lieberman, S. A., Hampl, J., et al., A TCR binds to antagonist ligands with lower affinities and faster dissociation rates than to agonists, Immunity, 5, 53-61, 1996.
72. Alam, S. M., Travers, P. J., Wung, J. L., et al., T-cell-receptor affinity and thymocyte positive selection, Nature, 381, 616-620, 1996.
73. Janeway, C. A. and Bottomly, K., Signals and signs for lymphocyte responses. Cell, 76, 275-285, 1994.
74. Sakihama, T., Smoylar, A., and Reinherz, E. L., Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules, Immunol. Today, 16, 581-587, 1995.
75. Podack, E. R. and Kupfer, A., T-cell effector functions: mechanisms for delivery of cytotoxicity and help, Annu. Rev. Cell. Biol., 7, 479-504, 1991.
76. Monks, C. R. F., Kupfer, H., Tamir, I., et al., Selective modulation of protein kinase c-theta during T-cell activation, Nature, 385, 83-86, 1997.
77. Shaw, A. S. and Dustin, M. L., Making the T cell receptor go the distance: a topological view of T cell activation. Immunity, 6, 361-369, 1997.
78. Hogquist, K. A., Tomlinson, A. J., Kleper, W. C., et al., Identification of a naturally occurring ligand for thymic positive selection, Immunity, 6, 389-399, 1997.
79. Liu, G. Y., Fairchild, P. J., Smith, R. M., et al., Low-avidity recognition of self-antigen by T cells permits escape from central tolerance, Immunity, 3, 407-415, 1995.
80. Nakano, N., Rooke, R., Benoist, C., et al., Positive selection of T cells induced by viral delivery of neopeptides to the thymus, Science, 275, 678-683, 1997.
81. Ignatowicz, L., Kappler, J., and Marrack, P., The repertoire of T cells shaped by a single MHC/peptide ligand, Cell, 84, 521-529, 1996.
82. Ignatowicz, L., Kappler, J., Parker, D. C., et al., The responses of mature T cells are not necessarily antagonized by their positively selecting peptide, J. Immunol., 157, 1827-1831, 1996.
83. Vidai, K. and Allen, P. M., The effect of endogenous altered peptide ligands on peripheral T-cell responses, Semin. Immunol., 8, 117-122, 1996.
84. Yagi, J. and Janeway, C. A. J., Ligand thresholds at different stages of T cell development, Int. Immunol., 2, 83-89, 1990.
85. Fukui, Y., Ishimoto, T., Utsuyama, M., et al., Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus, Immunity, 6, 401-410, 1997.
86. Hsu, B. L., Evavold, B. D., and Allen, P. M., Modulation of T cell development by an endogenous altered peptide ligand, J. Exp. Med., 181, 805-810, 1995.
87. Vidai, K., Hsu, B. L., Williams, C. B., et al., Endogenous altered peptide ligands can affect peripheral T cell responses, J. Exp. Med., 183, 1311-1321, 1996.
88. McMichael, A. J. and Phillips, R. E., Escape of human immunodeficiency virus from immune control, Annu. Rev. Immunol., 15, 271-296, 1997.
89. Klenerman, P., Rowland-Jones, S., McAdam, S., et al., Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants, Nature, 369, 403-407, 1994.
90. Bertoletti, A., Sette, A., Chisari, F. V., et al., Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells, Nature, 369, 407-410, 1994.
91. Davenport, M. P., Antagonists or altruists - do viral mutants modulate T cell responses, Immunol. Today, 16, 432-436, 1995.
92. Bieganowska, K. D., Ausubel, L. J., Modabber, Y., et al., Direct ex vivo analysis of activated, fas-sensitive autoreactive T cells in human autoimmune disease, J. Exp. Med., 185, 1585-1594, 1997.
93. Sakai, K., Zamvil, S. S., Mitchell, D. J., et al., Prevention of experimental encephalomyelitis with peptides that block interaction of T cells with major histocompatibility complex proteins, Proc. Natl. Acad. Sci. U.S.A., 86, 9470-9474, 1989.
94. s molecules, J. Immunol., 145, 1687-1693, 1990.
95. Janeway, C. A., Immunotherapy by peptides? Nature, 341, 342, 1989.
96. Nicholson, L. B., Greer, J. M., Sobel, R. A., et al., An altered peptide ligand mediates immune deviation and prevents experimental autoimmune encephalomyelitis, Immunity, 3, 397-405, 1995.
97. Pearson, C. I., van Ewijk, W., and McDevitt, H. O., Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatability complex in self-reactive transgenic mice, J. Exp. Med., 185, 583-599, 1997.
98. Brocke, S., Gijbels, K., Allegretta, M., et al., Treat ment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature, 379, 343-346, 1996.
99. Wucherpfennig, K. W. and Strominger, J. L., Molecular mimicry in T-cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein, Cell, 80, 695-705, 1995.